Genetic Variants ID Treatment Response in Psoriasis

This article originally appeared here.
Share this content:
Genetic Variants ID Treatment Response in Psoriasis
Genetic Variants ID Treatment Response in Psoriasis

TUESDAY, May 10, 2016 (HealthDay News) -- Genetic variants have been identified in psoriasis patients that correlate with anti-tumor necrosis factor (TNF)-α treatment response, according to research published online April 30 in the Journal of Dermatology.

Rika Nishikawa, M.D., from the Kobe University Graduate School of Medicine in Japan, and colleagues examined clinical biomarkers for predicting therapeutic responses or to serve as new drug targets for refractory psoriasis. Sixty-five patients were followed after initiating anti-TNF-α therapy. A genome-wide association study was conducted and correlations between single nucleotide polymorphisms (SNPs) and changes in the Psoriasis Area and Severity Index were examined after 12 weeks of treatment.

The researchers identified 731,442 SNPs in the psoriasis patients who were treated with adalimumab or infliximab. Ten SNPs, including those in JAG2 and ADRA2A, correlated with treatment responses to anti-TNF-α agents. Other SNPs were identified that showed potential correlations with anti-TNF-α treatment response; of these, rs11096957 on TLR10 was previously reported to be linked to treatment responses to TNF-α-inhibitors.

"The novel loci and reference list of candidate SNP highlighted herein warrant further investigation for pharmacogenetic studies of psoriasis patients," the authors write.

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

PSA Screening Rates Have Leveled Off in U.S.

PSA Screening Rates Have Leveled Off in U.S.

Decline followed recommendations from U.S. Preventive Services Task Force

Surgeon General Dismissed by Trump Administration

Surgeon General Dismissed by Trump Administration

Had served just over two years of his four-year term

Most Patients Willing to Provide Sexual Orientation Data

Most Patients Willing to Provide Sexual Orientation Data

However, emergency department providers expect most to refuse to provide the information

is free, fast, and customized just for you!

Already a member?

Sign In Now »